IZON designs and manufactures precision instrumentation for nano- and micro-scaled particle analysis.

Automated microscopy and image analysis
Real-time, label free cell analysis
Nano and micro particle analysis

Accelerate to discover
Related topics
Cytek webinar : Evaluating Spectral Cytometry for Immune Profiling in Viral Disease
Apr 19, 2021
In conventional fluorescence cytometry, each fluorophore in a panel is measured in a target detector, through the use...
Rethinking 3D cell culture with IncuCyte: advanced cell cultures from iPSCs and organoids
Apr 14, 2021
The world is neither flat nor two-dimensional, so why should cell culture be? Traditional cell culture systems grow...
The impact of environmental Oxygen content on Natural Killer Cell Immunotherapy
Apr 13, 2021
Natural Killer (NK) cells are being studied in the clinic in a number of settings, including solid tumor...
Mar 31, 2021
Cancer cells exhibit metabolic...
Cytek webinar recording : Improved flow cytometry assay resolution with autofluorescence extraction
Mar 30, 2021
The power of autofluorescence extraction in the detection of dim fluorescence on highly autofluorescent cells, and the...
Unleash Your Illumina Sequencer with TELL-Seq Linked Reads
Mar 24, 2021
Sage Science distributes universal sequencing technology´s TELL-Seq linked-read NGS library prep kits used with very...
Bruker webinar : High-resolution exploration of ESM-based vascularized tissue-flaps
Mar 22, 2021
By employing a tissue engineering approach based on biological tissue constructs, Dr. Redenski has fabricated composite...
A real time-saver, accurate cell counting in 15 seconds with C100 counter
Mar 17, 2021
Cell counters are tools for counting live and/or dead cells in a culture. Any researcher who works in a cell culture...
Feb 23, 2016
InnoMedica, a Swiss nanomedicine company led by Dr. Peter Halbherr, is working towards developing a new nanocarrier platform to transport anti-cancer drugs directly to tumours, thereby avoiding the toxic effect of the drug on healthy cells. The platform will deliver existing active agents, initially Doxorubicin, encapsulated in liposomes.
The use of Doxorubicin in liposomes is well established and now off patent, being originally released as Doxil. InnoMedica’s innovative step is to attach glycans to the surface of the liposomes. Glycans are polymers of carbohydrates, also known as polysaccharides. As an imitation of the detection system of inflammation sites of the immune system, the patented glycan based targeting quickly brings the drug to the cancer site - resulting in a better efficacy, lower dosage and less side effects.
The team at InnoMedica is developing the targeting platform with a first application called Talidox (Targeted Liposomal Doxorubicin). With the release of this drug, InnoMedica aims to improve cancer treatment of many cancer patients receiving chemotherapy. Talidox is now in the preclinical phase; however, research results suggest that cancer patients should have access to Talidox soon.
The Talidox product is developed and produced in the company’s clean room in Marly, Switzerland. One of their first analytical instruments was Izon Science’s qNano. Since last year, researchers at InnoMedica use the qNano to measure the number, size and zeta potential of their liposomes. Unlike dynamic light scattering (DLS), Tunable Resistive Pulse Sensing (TRPS) allows researchers to accurately and simultaneously measure the size and the number of individual liposomes and to provide a real number based distribution. This enables product development and manufacture to be performed with confidence. Pascal Halbherr, InnoMedica’s Production Project Leader said “Getting the qNano into our lab was a turning point and allowed us to be certain about what we were actually producing”.
Related technologies: Nano and micro particle analysis
Brand profile
IZON designs and manufactures precision instrumentation for nano- and micro-scaled particle analysis.
More info at:
www.izon.com